T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Healthcare Services Group
HCSG
$1.45B
| $753K | ﹤0.01% |
30,131
-900
| -3% | -$24.3K |
|
2177
Impinj
PI
$5.46B
| $753K | ﹤0.01% |
13,178
+1,030
| +8% | +$52.6K |
|
|
TELL
2178
DELISTED
Tellurian Inc.
TELL
| $753K | ﹤0.01% |
192,656
+122,294
| +174% | +$418K |
|
2179
NewMarket
NEU
$8.72B
| $752K | ﹤0.01% |
2,219
+25
| +1% | +$8.19K |
|
|
EGRX
2180
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $752K | ﹤0.01% |
13,475
-10
| -0.1% | -$492 |
|
2181
Center Bancorp
CNOB
$1.81B
| $748K | ﹤0.01% |
24,937
+100
| +0.4% | +$2.76K |
|
2182
Tactile Systems Technology
TCMD
$537M
| $745K | ﹤0.01% |
16,763
+1,468
| +10% | +$66K |
|
2183
Shutterstock
SSTK
$217M
| $744K | ﹤0.01% |
6,563
-43
| -0.7% | -$4.65K |
|
|
GTY
2184
Getty Realty Corp
GTY
$2.05B
| $740K | ﹤0.01% |
25,241
+151
| +0.6% | +$4.72K |
|
2185
Kura Oncology
KURA
$896M
| $737K | ﹤0.01% |
39,355
+6,336
| +19% | +$119K |
|
2186
Sinclair Inc
SBGI
$1.03B
| $732K | ﹤0.01% |
23,106
-2,251
| -9% | -$66.2K |
|
2187
Tennant Co
TNC
$1.15B
| $730K | ﹤0.01% |
9,870
-170
| -2% | -$12.8K |
|
2188
First Busey Corp
BUSE
$2.58B
| $727K | ﹤0.01% |
29,519
+132
| +0.4% | +$3.12K |
|
2189
Fresenius Medical Care
FMS
$12.6B
| $726K | ﹤0.01% |
20,758
-17,616
| -46% | -$688K |
|
2190
Kite Realty
KRG
$5.31B
| $726K | ﹤0.01% |
35,661
-3,400
| -9% | -$69K |
|
|
NXGN
2191
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $725K | ﹤0.01% |
51,405
+5,100
| +11% | +$79.3K |
|
2192
Virtu Financial
VIRT
$5.05B
| $721K | ﹤0.01% |
29,522
-1,562
| -5% | -$39.7K |
|
2193
Hamilton Lane
HLNE
$5.91B
| $717K | ﹤0.01% |
8,458
| – | – |
|
2194
Hovnanian Enterprises
HOV
$799M
| $716K | ﹤0.01% |
7,430
-3,110
| -30% | -$310K |
|
2195
Innoviva
INVA
$1.5B
| $715K | ﹤0.01% |
42,764
-8,210
| -16% | -$123K |
|
2196
Senseonics Holdings Inc
SENS
$409M
| $713K | ﹤0.01% |
10,522
+2,747
| +35% | +$186K |
|
|
CONN
2197
DELISTED
Conn's Inc.
CONN
| $713K | ﹤0.01% |
31,249
-5,200
| -14% | -$124K |
|
|
SRDX
2198
DELISTED
Surmodics
SRDX
| $712K | ﹤0.01% |
12,797
+68
| +0.5% | +$3.78K |
|
|
WIRE
2199
DELISTED
Encore Wire Corp
WIRE
| $712K | ﹤0.01% |
7,507
+20
| +0.3% | +$1.64K |
|
2200
Chefs' Warehouse
CHEF
$4.57B
| $709K | ﹤0.01% |
21,767
+124
| +0.6% | +$3.64K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.